Vaccine for use in the prophylaxis and/or treatment of a disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12023377
APP PUB NO 20220347291A1
SERIAL NO

17732076

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INPROTHER APSCOPENHAGEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Holst, Peter Soeborg, DK 13 38
Neukirch, Lasse Flensburg, DE 5 4
Thirion, Christian Munich, DE 23 113

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 2, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 2, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 2, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00